ArticleCancers2021

Alterations in HLA Class I-Presented Immunopeptidome and Class I-Interactome upon Osimertinib Resistance in EGFR Mutant Lung Adenocarcinoma.

Yue A Qi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.